Display options
Share it on

Eur J Case Rep Intern Med. 2021 Sep 02;8(9):002807. doi: 10.12890/2021_002807. eCollection 2021.

Recurrence of Graves' Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence?.

European journal of case reports in internal medicine

Guillaume Pierman, Etienne Delgrange, Corinne Jonas

Affiliations

  1. Department of Endocrinology, Centre Hospitalier Universitaire de Mont-Godinne, Yvoir, Belgium.

PMID: 34671577 PMCID: PMC8523378 DOI: 10.12890/2021_002807

Abstract

Graves' disease is the most frequent cause of hyperthyroidism in young women. This auto-immune disease is due to the production of class 1 IgG stimulating the TSH receptor. These antibodies are produced secondary to a Th1 immune response in which interferon gamma plays a key role. Vaccination is ongoing worldwide against SARS-CoV-2 and some of the vaccines include mRNA which seems to stimulate the Th1 immune response. Here, we report a case of recurrence of hyperthyroidism due to Graves' disease following mRNA vaccination and discuss the possible implicated mechanism. This observation argues for a systematic study of a population of patients with previous Graves' disease in order to assess the risk of recurrence following vaccination.

LEARNING POINTS: Graves' disease is a Th1-mediated immune disease in which interferon gamma plays a key role.The recurrence of hyperthyroidism due to Grave's disease should be monitored in patients exposed to risk factors.

© EFIM 2021.

Keywords: Graves’ disease; Hyperthyroidism; SARS-CoV-2; vaccine

Conflict of interest statement

Conflicts of Interests: The authors declare there are no competing interests.

References

  1. Lancet. 1999 Nov 13;354(9191):1691-5 - PubMed
  2. Nature. 2020 Oct;586(7830):594-599 - PubMed
  3. J Clin Endocrinol Metab. 2014 Nov;99(11):4060-1 - PubMed
  4. CMAJ. 2018 May 28;190(21):E648-E655 - PubMed
  5. Thyroid. 2021 Sep;31(9):1436-1439 - PubMed

Publication Types